Northpond Ventures
Biotechnology
Investor profile
Venture capitalInvestments
1
1 of them startups
Hiring now
0
companies with open roles
Stage of its companies
Series C and later 100%
Sources: 2 rounds in the press that name it
News
Mice Don't Menstruate: It's Time to Prioritize Women's Hormonal Health
Sharon Kedar is Co-Founder, Partner of Northpond Ventures. Lucy Pérez is a Senior Partner in McKinsey & Company and the Global Leader of the McKinsey Health Institute. Shelley Zalis is the Founder and CEO of the Female Quotient. This article was originall
Read more
Report
Stanford Medicine and Northpond Ventures Announce Launch of The Northpond Laboratories
The program will translate scientific discoveries out of the lab and into clinical and commercial applications.
Read more
Report
Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
Read more
Report
MIT-Northpond Program Created to Advance Innovation in Engineering and Life Science
Cambridge, MA June 15, 2022 - MIT School of Engineering and Northpond Ventures today announced the launch of the MIT-Northpond Program - Advancing Life Science & Engineering Innovation. The five-year engagement is funded through Northpond Labs, the resear
Read more
Report
Northpond Labs funds second Wyss Institute research project
Through the Laboratory for Bioengineering Research and Innovation, Northpond will sponsor SomaCode to support commercialization By Lindsay Brownell (BOSTON) - The Wyss Institute for Biologically Inspired Engineering at Harvard University and Northpond Ven
Read more
Report
MIT Future Founders Initiative Announces Prize Competition to Promote Female Entrepreneurs in Biotech
Read more at MIT News Nine MIT researchers selected as finalists for 2021 prize supported by Northpond Ventures; grand prize winner to receive $250K toward commercializing her human health-related invention November 30, 2021 - In a fitting sequel to its e
Read more
Report
Kytopen Raises $30M in Series A Funding, Led by Northpond Ventures, to Transform Non-Viral Delivery via the Flowfect Platform
Read more
Report
Syapse Announces $68 Million Strategic Investment with Ally Bridge Group and Northpond Ventures to Expand Delivery of Real-World Evidence Through Syapse's Learning Health Network
-- Financing to support expanded partnering opportunities with life sciences, health systems, regulators and molecular labs -- -- Syapse committed to delivering real-world insights to improve outcomes for people with cancer -- SAN FRANCISCO and NEW YORK a
Read more
Report
Show more news